The value of the RA market in the APAC region amounted to an estimated $5.6 billion in 2014 and is expected to register a Compound Annual Growth Rate (CAGR) of 3.3% to reach $6.9 billion by 2021. The key drivers for growth in the APAC market include: the increasing prevalent population and the anticipated market launch of promising pipeline candidates. Browse Full Report With TOC @ http://www.researchmoz.us/rheumatoid-arthritis-therapeutics-in-asia-pacific-markets-to-2021-novel-il-6-and-jak-inhibitors-to-stimulate-moderate-growth-despite-brand-erosion-of-blockbuster-anti-tnfs-report.html
http://www.researchmoz.us/rheumatoid-arthritis-therapeutics-in-asia-pacific-markets-to-2021-novel-il-6-and-jak-inhibitors-to-stimulate-moderate-growth-despite-brand-erosion-of-blockbuster-anti-tnfs-report.html
No comments:
Post a Comment